Article
Transcriptional signature of flavopiridol-induced tumor cell death
1 Jul 2004
Abstract excerpt
Flavopiridol has been shown to inhibit the proliferation of a variety of human tumor cells and is currently undergoing clinical evaluation in cancer treatment. Although the antiproliferative effect of flavopiridol has been attributed to the inhibition of cyclin-dependent kinases 2 and 4, recent reports indicate that the mechanism responsible for the cell death induced by this agent is more complex. To provide...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
